SCHEMBL1639283

SCHEMBL1639283

OCc1cccc(C2=CC3=CC4=NC(=C(c5ccccc5)C5=NC(=C(c6ccccc6)C6=NC(=C(c7ccccc7)C2=N3)C=C6)C=C5)C=C4)c1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.33
▸ FYN P06241 2/20 0.30
▸ HTR1A P08908 1/20 0.30
▸ GPR68 Q15743 1/20 0.30
▸ CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1640993 0.87 HSD17B1 (0.31) —
SCHEMBL28024657 0.87 — —
SCHEMBL27883625 0.85 — —
SCHEMBL28008851 0.84 — —
SCHEMBL18917419 0.84 MAOA (0.34) —
SCHEMBL18917439 0.83 KMO (0.37) —
SCHEMBL28188074 0.83 — —
SCHEMBL28311234 0.82 MMP3 (0.33) —
SCHEMBL28121970 0.82 MAOA (0.33) —
SCHEMBL28164514 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493897-A1 HYDROXY-SUBSTITUTED GOLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS The University of Hong Kong (CN) 2012-09-05 — — EP claimed
WO-2011050575-A1 HYDROXY-SUBSTITUTED GOLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS THE UNIVERSITY OF HONG KONG (CN) 2011-05-05 — — WO claimed
US-20110098263-A1 HYDROXY-SUBSTITUTED COLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS CHE CHI MING 2011-04-28 — — US claimed
US-8563712-B2 Hydroxy-substituted gold(III) porphyrin complexes as histone deacetylase inhibitors THE UNIVERSITY OF HONG KONG (HK) 2013-10-22 — — US disclosed
EP-2493897-A1 HYDROXY-SUBSTITUTED GOLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS The University of Hong Kong (CN) 2012-09-05 — — EP disclosed
WO-2011050575-A1 HYDROXY-SUBSTITUTED GOLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS THE UNIVERSITY OF HONG KONG (CN) 2011-05-05 — — WO disclosed
US-20110098263-A1 HYDROXY-SUBSTITUTED COLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS CHE CHI MING 2011-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098263-A1 HYDROXY-SUBSTITUTED COLD(III) PORPHYRIN COMPLEXES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC8, HDAC3 PRKCI 2326/4885FYN 4497/4885HTR1A 4640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback